Contents

Search


H5N1 influenza vaccine; avian flu vaccine (Audenz)

Indications: - monovalent adjuvanted vaccine for the prevention of H5N1 influenza (FDA-approved Nov 2013) Notes: - 1st vaccine 2006 - 12-fold higher dose than standard influenza vaccine required for protective activity

General

influenza virus vaccine, inactivated (Fluogen, Fluzone, Fluvirin, Flushield, Fluarix, Flulaval, Agriflu, Afluria, Flublok Quadrivalent, FluCelVax, Fluad, RIV4)

References

  1. Trenor JJ et al, Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine N Engl J Med 2006; 354:1343 PMID: 16571878 - Poland GA Vaccines against avian influenza - a race against time. N Engl J Med 2006; 354:1411 PMID: 16571885
  2. Bresson JL, Perronne C, Launay O, Gerdil C, Saville M, Wood J, Hoschler K, Zambon MC. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet. 2006 May 20;367(9523):1657-64. PMID: 16714186
  3. FDA advisory panel backs prototype Glaxo bird flu virus Nov 14 2012 (Reuters) http://www.reuters.com/article/2012/11/14/glaxo-birdflu-vaccine-idUSL1E8MEJ8U20121114
  4. FDA News Release: Nov. 22, 2013 FDA approves first adjuvanted vaccine for prevention of H5N1 avian influenza. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376444.htm
  5. Brooks M FDA Approves Novel Pandemic Influenza Vaccine. Medscape - Feb 03, 2020. https://www.medscape.com/viewarticle/924729